Replies to post #252016 on Biotech Values

[DewDiligence]

Re: MRK/MRNA cancer vaccine

From the post I'm replying to:

MRNA says the FDA may consider mRNA-4147 for accelerated approval in melanoma based on the above phase-2b data when MRNA’s new manufacturing facility for this product in Marlborough, MA comes online.

Today (during MRNA's Investor Day presentation), MRNA acknowledged that FDA accelerated approval for mRNA-4147 based on phase-2 data is no longer under consideration